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The ovine maedi-visna (MVV) and caprine arthritis-encephalitis (CAEV) small ruminant lentiviruses (SRLV) exhibit differ-
ential species tropism and cytopathic effects in vitro. Icelandic MVV-K1514 is a lytic SRLV which can infect cells from many
species in addition to ruminants, whereas a lytic North American MVV strain (85/34) as well as nonlytic MVV strain S93 and
CAEV can infect only ruminant cells. In the present study, we determined if differential receptor usage in sheep and goat cells
is the basis of differential species tropism or cytopathic phenotype of SRLV. Infection interference assays in sheep and goat
synovial membrane cells using pseudotyped CAEV vectors showed that North American MVV strains 85/34 and S93 and
CAEV use a common receptor (SRLV receptor A), whereas MVV-K1514 uses a different receptor (SRLV receptor B). In
addition, human 293T cells expressing CAEV but not MVV-K1514 envelope glycoproteins fused with a goat cell line
persistently infected with MVV-K1514, indicating that MVV-K1514 does not use SRLV receptor A for cell-to-cell fusion.
Therefore, our results indicate that the differential species tropism of SRLV is determined by receptor usage. However,INTRODUCTION
The ovine maedi-visna (MVV) and caprine arthritis-
encephalitis (CAEV) lentiviruses cause progressive sy-
novitis, pneumonia, mastitis, and encephalitis in sheep
and goats (Crawford et al., 1980; Narayan et al., 1980,
1993). Like other lentiviruses, small ruminant lentiviruses
(SRLV) infect cells of the monocyte/macrophage lineage
and dendritic cells (Gendelman et al., 1985, 1986; Gorrel
et al., 1992; Narayan et al., 1983; Ryan et al., 2000).
However, MVV can also enter other cell types in vivo,
indicating that expression of MVV receptors is not re-
stricted to monocytes, macrophages, and dendritic cells
(Brodie et al., 1995; Georgsson et al., 1989). Indeed, the
long terminal repeat appears to be a major determinant
of MVV tropism in vitro and may be an important factor in
MVV pathogenesis (Agnarsdo´ttir et al., 2000). Whether
receptors used for entry also have a role in the patho-
genesis of SRLV infections is not known.
Infection of cells in vitro by different SRLV strains
results in either complete lysis of monolayers or persis-
tent nonlytic infection with syncytium formation (Que´rat
et al., 1984). CAEV strains are nonlytic while MVV strains
can be either lytic or nonlytic. The basis for the differen-
tial cytopathic phenotype of SRLV is not known but could
be related to receptor usage, similar to the relationship
1 To whom correspondence and reprint requests should be ad-21between receptor usage and cytopathic phenotype of
avian retroviruses (Adkins et al., 2001; Dorner and Coffin,
1986). In this regard, a previous study showed that viri-
ons from the lytic MVV-K1514 have different binding sites
on sheep and goat cells than virions from the nonlytic
MVV-S93 and CAEV, suggesting the possibility of a dif-
ferential SRLV receptor usage related to cytopathic phe-
notype (Jolly and Narayan, 1989). SRLV also differ in host
range in vitro, consistent with a differential receptor us-
age of SRLV (Ho¨tzel and Cheevers, 2001). However, host
range is not related to cytopathic phenotype as the lytic
MVV-K1514 can infect cells from a broad range of spe-
cies whereas the lytic MVV-85/34, similar to CAEV and
MVV-S93, can only infect cells of ruminant species (Ho¨t-
zel and Cheevers, 2001; Mselli-Lakhal et al., 2000). Thus,
if SRLV cytopathic phenotype is related to receptor us-
age, lytic MVV strains use multiple receptors which are
different from the nonlytic SRLV receptor(s). Alternatively,
either cytopathic phenotype or host range is not related
to receptor usage.
Here we determined the receptor usage of SRLV
strains of different cytopathic phenotypes and host range
in sheep (SSM) and goat (GSM) synovial membrane
cells. Receptor usage of CAEV and MVV strains was
determined by infection interference assays using
pseudotyped CAEV vectors and syncytial assays. We
show that lytic and nonlytic North American MVV strains
and CAEV use a common receptor for entry while thereceptor usage is unrelated to cytopathic phenotype. © 2
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SRLV receptor usage is related to host range but not
cytopathic phenotype.
RESULTS
Production of recombinant soluble CAEV and MVV
envelope surface glycoproteins (SU)
We produced recombinant soluble SU from four SRLV
strains for the interference assays: CAEV-63, the lytic and
nonlytic North American MVV strains 85/34 and S93, and
the lytic Icelandic MVV-K1514. Recombinant soluble SU
was produced by transfecting 293T cells with envelope
plasmids with stop codons or frameshift mutations in the
transmembrane subunit (TM) just before the TM anchor
(Fig. 1A). Production of recombinant soluble SU was
assessed by immunoprecipitation of supernatants from
transfected cells labeled with [35S]methionine. Immune
serum from CAEV-infected goat 8517 immunoprecipi-
tated glycoproteins of 135 kDa from supernatants of
cells transfected with plasmids pCMV63S, pCMV93S,
pCMV34S, or pCMV1514S, expressing soluble SU from
CAEV-63, MVV-S93, MVV-85/34, and MVV-K1514, respec-
tively (Fig. 1B, lanes 2, 4, 6, and 8), but not from super-
natants of cells transfected with control plasmid pCR3
(Fig. 1B, lane 10). In contrast, serum from uninfected
control goat 8505 did not immunoprecipitate any labeled
proteins from the supernatants of transfected 293T cells
(Fig. 1B, lanes 1, 3, 5, and 7). The CAEV-63, MVV-S93, and
MVV-K1514 recombinant SU comigrated with the SU of
wild-type CAEV-63 grown in GSM cells (Fig. 1B, lanes 2,
4, 8, and 9) while the recombinant MVV-85/34 SU mi-
grated somewhat faster (Fig. 1B, lane 6), as previously
observed for wild-type MVV-85/34 SU expressed by in-
fected GSM cells (unpublished data). Serum 8517 also
immunoprecipitated TM glycoproteins of the expected
size from the supernatants of cells transfected with
pCMV63S, pCMV93S, and pCMV34S, migrating as broad
bands in the 25-kDa regions as well as discrete bands in
the 20-kDa region (Fig. 1B, lanes 2, 4, and 6), in contrast
to the native monomeric and oligomeric TM forms mi-
grating in the 38- and 90-kDa regions, respectively (Fig.
1B, lane 9) (McGuire et al., 1992). A weak band in the
36-kDa region was observed in immunoprecipitates
of MVV-K1514 Env supernatants that may represent
oligomerized forms of truncated TM (Fig. 1B, lane 8). The
results confirm production of recombinant CAEV and
MVV soluble SU and TM by transfected 293T cells.
CAEV and North American MVV strains share a
common receptor in sheep and goat cells
Receptor usage of SRLV strains was determined by
infection interference assays using a modification of a
previously described assay (Hullinger, 1993; Hullinger et
al., 1993). GSM or SSM cells were incubated with soluble
SU and challenged with pseudotyped virus to determine
whether receptors used for entry by each strain are
bound and blocked by homologous or heterologous sol-
uble SU. For virus challenge we used vector CAEVneo
pseudotyped with CAEV or MVV envelopes (Ho¨tzel and
Cheevers, 2001). The use of CAEVneo allowed the direct
quantitation of virus entry events by counting the number
of G418-resistant colonies after staining with crystal vio-
let. In the interference assays, the number of available
receptors, and thus virus infectivity, is reduced according
to the concentration of soluble SU and its receptor-
binding affinity. However, these assays are also time-
FIG. 1. Production of soluble recombinant envelope glycoproteins. (A)
Schematic representation of recombinant soluble Env glycoprotein
constructs. The SU and TM domains are shown in black and gray,
respectively. The TM transmembrane anchor in the wild-type glycop-
roteins is indicated by a dark gray box. Frameshift mutations are
indicated by arrowheads and stop codons by asterisks. The white
boxes represent nontranslated env sequences downstream from intro-
duced stop codons. (B) SDS–PAGE analysis of immunoprecipitated
MVV recombinant soluble envelope glycoproteins. Human 293T cells
were transfected with plasmids pCMV63S and pCRev63 (63, lanes 1
and 2), pCMV93S (S93, lanes 3 and 4), pCMV34S (85/34, lanes 5 and 6),
pCMV1514S (K1514, lanes 7 and 8), or pCR3 (lane 10) and labeled with
[35S]methionine. Filtered supernatants of transfected cells were immu-
noprecipitated with serum from CAEV-63-infected goat 8517 (G17, lanes
2, 4, 6, 8, and 10) or from uninfected goat 8505 (G05, lanes 1, 3, 5, and
7). Lane 9 (63wt) shows an immunoprecipitation of 35S-labeled CAEV-63
with serum 8517. The positions of SU and wild-type TM [TM(wt)] gly-
coproteins from CAEV-63 are indicated on the right by arrows. The
positions of truncated recombinant TM glycoproteins [TM(rec)] are
indicated on the right by a bracket. The positions of 14C-labeled mo-
lecular markers are shown on the left.
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dependent as maximal virus entry will eventually occur
regardless of the presence of soluble SU. Thus, one
critical parameter for this assay is the time of exposure
of cells to virus. Incubation of GSM cells with CAEVneo
pseudotyped with SRLV envelopes for 1 h at 37°C usu-
ally yielded titers that were 30 to 50% of the titers ob-
tained by incubating cells with virus for 24 h (not shown).
Therefore, incubation of virus with cells for 1 h should not
overcome the blocking activity of soluble SU, as previ-
ously shown for GSM cells incubated with recombinant
CAEV-63 SU and CAEV-63 (Hullinger et al., 1993). Another
important parameter to achieve maximum inhibition in
this type of assay is the time required for SU–receptor
binding to achieve equilibrium. The binding kinetics of
CAEV and MVV SU to their receptors are not known.
However, previous results showed that addition of
CAEV-63 to GSM cells simultaneously or 1 h after addi-
tion of purified CAEV-63 SU does not significantly affect
the 50% inhibitory concentration (IC50) of SU (Hullinger,
1993), indicating that equilibrium or near-equilibrium
conditions are achieved in less than 1 h at 37°C. There-
fore, for the interference assays, GSM and SSM cells
were incubated with soluble SU for 1 h at 37°C, chal-
lenged with 100 colony-forming units (CFU) of
pseudotyped CAEVneo (multiplicity of infection 5 
104 CFU per cell) in the presence of SU for 1 additional
h at 37°C, washed, incubated in growth medium for 24 h,
and then grown in selective medium.
The CAEV-CO pseudotype [CAEVneo(CO)] titers in
GSM or SSM cells incubated with recombinant soluble
SU of CAEV or North American MVV strains 85/34 and
S93 ranged from 0 to 18.8% of the titer of CAEVneo(CO) in
cells incubated with control supernatant (Table 1), indi-
cating efficient cross-interference between these strains.
As expected, recombinant soluble SU preparations did
not significantly reduce the titers of CAEVneo(VSV) in
GSM or SSM cells (Table 1), indicating that interference
in these assays occurs at the entry level. Thus, CAEV
and North American MVV strains share at least one
receptor in GSM and SSM cells, tentatively designated
SRLV receptor A.
Results of interference assays with CAEVneo(S93)
were generally similar to those with interference assays
with CAEVneo(CO), except that residual titers were
somewhat higher with CAEVneo(S93) (Table 1). CAEV-
neo(S93) titers in cells incubated with soluble SU from
CAEV or North American MVV strains ranged from 4.1 to
15.7% of the titers in cells incubated with control super-
natant except for SSM cells incubated with CAEV-63 SU,
in which CAEVneo(S93) titers were 58.2% compared to
controls (Table 1). The less efficient interference of CAE-
Vneo(S93) by CAEV-63 SU in SSM cells could be due to
the presence of an additional receptor for MVV-S93 in
SSM cells not bound by CAEV-63 SU or a lower affinity of
CAEV-63 SU in SSM compared to GSM cells. To deter-
mine whether incubation of SSM cells with higher
CAEV-63 SU concentrations would further reduce MVV-
S93 infectivity, we performed interference assays with
serial dilutions of purified native CAEV-63 SU in SSM
cells. Similar to the results obtained with undiluted re-
TABLE 1
Interference Assays of Pseudotyped CAEVneo with Recombinant Soluble SU in GSM and SSM Cells
Soluble SUa
Percentage Infectivity of Pseudotypeb
CAEVneo(CO) CAEVneo(S93) CAEVneo(85/34) CAEVneo(K1514) CAEVneo(VSV)
None (pCR3)
GSM 100.0 17.0 100.0 2.5 100.0 3.7 100.0 1.9 100.0 3.1
SSM 100.0 3.1 100.0 3.9 100.0 1.9 100.0 8.4 100.0 1.1
CAEV-63
GSM 5.2 2.2 9.1 4.1 85.5 2.5 91.8 3.1 103.7 2.3
SSM 18.8 3.1 58.2 2.7 94.6 1.0 84.1 5.2 96.5 4.6
MVV-S93
GSM 8.1 3.7 15.7 0.8 85.5 5.8 93.0 5.8 103.6 4.1
SSM 0 0 14.1 3.6 75.2 0.6 90.4 5.2 91.2 4.2
MVV-85/34
GSM 0 0 4.1 0.8 62.7 3.7 92.2 1.9 96.3 2.3
SSM 0 0 5.9 1.2 51.0 1.3 89.6 8.4 96.5 1.1
MVV-K1514
GSM 107.4 7.6 90.9 3.6 95.4 4.3 108.9 0.7 100.9 1.4
SSM 95.3 8.2 100.4 1.2 99.0 1.6 101.6 2.0 97.9 0.4
a Supernatants of transfected 293T cells containing recombinant soluble SU were used undiluted. The same batches of SU of each strain were used
for assays in GSM and SSM cells.
b Values represent titers of CAEVneo in cells incubated with soluble SU as a percentage of titers in cells incubated with control (pCR3) supernatants
(mean  range; n  2). Highlighted numbers indicate 25% titer reduction. Representative results of two experiments performed in duplicate are
shown.
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combinant soluble CAEV-63 SU shown in Table 1, incu-
bation of SSM cells with 5 nM purified native CAEV-63
SU was sufficient to decrease the titers of CAEVneo(CO)
by 83%, while CAEVneo(S93) titers were reduced by
only 53% (Fig. 2B). However, higher concentrations of
CAEV-63 SU reduced infectivity of CAEVneo(S93) in SSM
cells by up to 89% (Fig. 2B), indicating that MVV-S93 does
not efficiently use a receptor in SSM cells that is not
bound by CAEV-63 SU. Thus, CAEV and MVV-S93 share
the same set of receptors in GSM and SSM cells.
Unlike the efficient interference observed for CAEV-
neo(CO) and CAEVneo(S93) by their respective homolo-
gous recombinant soluble SU and by MVV-85/34 SU,
titers of CAEVneo(85/34) were only partially reduced by
MVV-85/34 SU in either GSM or SSM cells (Table 1). In
addition, MVV-S93 SU partially reduced CAEVneo(85/34)
titers only in SSM cells, while recombinant soluble
CAEV-63 SU partially reduced CAEVneo(85/34) titers only
in GSM cells (Table 1). To determine whether this partial
or absent interference of CAEVneo(85/34) was due to low
SU concentrations or a one-way interference between
these strains, interference assays of CAEVneo(85/34)
were performed using serial dilutions of purified native
CAEV-63 SU. The ability of MVV-85/34 SU to efficiently
block CAEVneo(CO) infectivity in GSM and SSM cells
indicated that MVV-85/34, like CAEV and MVV-S93, also
uses SRLV receptor A for infection. Thus, some interfer-
ence of CAEVneo(85/34) by CAEV-63 would be expected.
In fact, a partial reduction of CAEVneo(85/34) titers by
purified native CAEV-63 SU was observed in GSM and
SSM cells (Figs. 2A and 2B). This partial reduction of
CAEVneo(85/34) titers was observed even at CAEV-63
SU concentrations as high as 500 nM, while CAEV-
neo(CO) was almost completely blocked by CAEV-63 SU
at 16 nM (Figs. 2A and 2B). Increasing concentrations of
CAEV-63 SU over 50 nM did not appear to further reduce
titers of CAEVneo(85/34). The 95% confidence intervals
for the maximal inhibition of CAEVneo(85/34) by CAEV-63
SU in GSM and SSM cells in the experiments shown in
Fig. 2 were 33  3.3% and 33.5  8.3%, respectively.
Binding of MVV-85/34 to sheep and goat cells does
not depend on receptors used for entry
Although MVV-85/34 uses SRLV receptor A for entry,
the results in Figs. 2A and 2B suggest that MVV-85/34
Env can bind a second receptor in GSM and SSM cells.
One interpretation is that MVV-85/34 uses a second
receptor for entry. An alternative possibility is that MVV-
85/34, but not other SRLV strains, remains bound to GSM
or SSM cells during challenge in the presence of SU and
then infects the cells upon withdrawal of soluble SU. To
test this second possibility, GSM cells were incubated
with serial dilutions of CAEV-63 SU for 1 h and then
challenged for 1 h with CAEVneo(85/34). Unbound virus
and SU were then aspirated and cells washed and incu-
bated for 24 h in growth medium with or without 160 nM
purified CAEV-63 SU before G418 selection. Similar to the
results in Fig. 2A, incubation of GSM cells with CAEV-63
SU only during the period of challenge decreased the
infectivity of CAEVneo(85/34) by a maximum of only 54%
(Fig. 3A). However, CAEV-63 SU added after unbound
virus was washed from the cells inhibited CAEVneo(85/
34) entry completely (Fig. 3A). Similar results were also
obtained with SSM cells (not shown). Thus, the MVV-
85/34 envelope can mediate binding but not infection of
GSM and SSM cells independently of SRLV receptor A,
allowing infection of cells through SRLV receptor A after
soluble SU is removed.
MVV-K1514 is resistant to interference by CAEV and
North American MVV SU
Unlike CAEVneo pseudotyped with CAEV or North
American MVV envelopes, CAEVneo(K1514) titers were
not significantly reduced by preincubation of GSM and
FIG. 2. Interference assays using serial dilutions of soluble SU in
GSM (A) and SSM (B) cells. Cells were incubated with serial dilutions
of purified CAEV-63 SU in DMEM with 10% FBS for 1 h, challenged with
100 CFU of pseudotyped CAEVneo in the presence of SU for 1 addi-
tional h, washed twice in DMEM, and processed for titration as previ-
ously described. Each point represents the average (n  2) and range
of titers of each virus in cells incubated with soluble SU relative to the
titer of each virus in cells incubated with 60 g/ml of BSA in DMEM.
Data were fitted by nonlinear regression using a one-site competition
model with GraphPad Prism software, Version 2.01.
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SSM cells with CAEV-63, MVV-S93, or MVV-85/34 recom-
binant soluble SU (Table 1). To determine whether higher
concentrations of SU can block CAEVneo(K1514) infec-
tion, interference assays of this pseudotype were also
performed with serial dilutions of purified CAEV-63 SU.
As shown in Fig. 2A, higher concentrations of CAEV-63
SU were not able to decrease the titers of CAEV-
neo(K1514) in GSM cells, suggesting that MVV-K1514
either does not use SRLV receptor A or uses a second
receptor efficiently in addition to SRLV receptor A. As the
partial inhibition of CAEVneo(85/34) by CAEV-63 SU is
due to binding of virus to cells through mechanisms
independent of receptors used for entry, we asked
whether the failure of soluble SU to interfere with CAE-
Vneo(K1514) was due to a similar binding and infection
after removal of SU. To determine this, GSM cells were
incubated with 500 nM of purified CAEV-63 SU, chal-
lenged with CAEVneo(K1514), washed, and further
incubated in growth medium with or without 160 nM of
purified CAEV-63 SU. Similar to the results in Fig. 2,
incubation of GSM cells with CAEV-63 SU before
and during the challenge period inhibited the infectivity
of CAEVneo(S93) by 98% while infectivity of CAEV-
neo(K1514) was unaffected by preincubation with
CAEV-63 SU (Fig. 3B). However, continued incubation of
GSM cells with 160 nM CAEV-63 SU after removal of
unbound virus completely blocked CAEVneo(S93) infec-
tivity but did not significantly affect CAEVneo(K1514) titers
(Fig. 3B). This contrasts the almost complete reduction in
titer of CAEVneo(85/34) under the same conditions (Fig.
3A). The results indicate that resistance of CAEV-
neo(K1514) to interference by CAEV-63 SU is not due to
receptor-independent binding. Instead, it appears that
MVV-K1514 uses a second receptor, SRLV receptor B, for
entry into sheep and goat cells.
MVV-K1514 cannot use SRLV receptor A for cell-to-
cell fusion
Incubation of GSM or SSM cells with MVV-K1514 re-
combinant soluble SU preparations similar to the soluble
SU from North American MVV strains failed to interfere
with the infection of any CAEVneo pseudotype, including
the homologous CAEVneo(K1514) (Table 1). Thus, a dif-
ferent approach was devised to test interference of SRLV
by MVV-K1514 SU. While it has not been possible to
derive cell lines where most or all cells are persistently
infected with CAEV or North American MVV strains with-
out cytopathic effects, at least one goat cell line has
been persistently infected with the Icelandic MVV-
KV1772 without cytopathic effects (Andresson et al.,
1993). This suggests that some cell lines can be persis-
tently infected by Icelandic MVV strains which display
homologous receptor interference. Thus, we developed
a goat synovial membrane cell line persistently infected
with MVV-K1514. The SV40-immortalized goat synovial
membrane cell line TIGEF (Da Silva Teixeira et al., 1997)
was infected with MVV-K1514 at a high multiplicity of
infection and the surviving cells, designated T1514 cells,
were passaged uncloned. The persistently infected
T1514 cell line produced infectious cytopathic MVV-
K1514 and had a normal fibroblast-like morphology, al-
though growing more slowly than the parental TIGEF cell
line (not shown). As TIGEF and T1514 cells fail to form
visible colonies after infection with CAEVneo(VSV), prob-
ably due to downregulation of the neo SV40 promoter by
the SV40 large T antigen and the lower plating efficiency
of the infected cells, we used cell-to-cell fusion assays to
determine receptor interference. Human 293T cells were
transfected with plasmids expressing MVV-K1514 or
FIG. 3. Interference assays in the continued presence of soluble
CAEV-63 SU. (A) GSM cells were incubated with serial dilutions of
CAEV-63 SU in DMEM–10% FBS for 1 h (shown in x-axis), challenged
with 100 CFU of pseudotyped CAEVneo(85/34) in the presence of
CAEV-63 SU for 1 additional h, washed twice with DMEM, and incu-
bated in DMEM–10% FBS with 160 nM BSA (CAEV SU/BSA, solid
circles) or 160 nM CAEV-63 SU (CAEV SU/CAEV SU, open circles)
before G418 selection. Points represent average (n  2) of the titer of
virus in cells incubated with different CAEV-63 SU concentrations
relative to titer in cells incubated without SU during challenge. (B) GSM
cells were incubated with 500 nM CAEV-63 SU or BSA for 1 h, chal-
lenged with 100 CFU of pseudotyped CAEVneo(S93) or (K1514) in the
presence of CAEV-63 SU for 1 additional h, washed twice with DMEM,
and incubated in DMEM–10% FBS with 160 nM BSA (CAEV SU/BSA,
cross-hatched bars) or CAEV-63 SU (CAEV SU/CAEV SU, white bars)
before G418 selection. Titers are normalized with the titer of
pseudotyped virus in GSM cells preincubated with BSA (BSA/BSA,
black bars). Error bars in A and B and represent titer ranges.
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CAEV-CO Env or control plasmid pCR3 and cocultured
overnight with TIGEF or T1514 cells. TIGEF and T1514
cells cocultured with 293T cells transfected with plasmid
pCR3 did not form syncytia, except for small scattered
syncytia present in both normal TIGEF and T1514 cells
(Figs. 4A and 4B). This indicates that cell surface expres-
sion of MVV-K1514 Env in the persistently infected T1514
cells is insufficient to induce significant fusion with the
human 293T cells. As expected, TIGEF cells cocultured
with 293T cells expressing MVV-K1514 Env formed large
syncytia (Fig. 4C). In contrast, T1514 cells cocultured with
the same 293T cells expressing MVV-K1514 did not form
any significant syncytia (Fig. 4D), indicating that T1514
cells lack receptors for induction of cell-to-cell fusion by
MVV-K1514. To determine whether functional SRLV re-
ceptor A is expressed on the surface of T1514 cells, we
performed fusion assays with CAEV-CO Env, which rec-
ognizes this receptor. In contrast to the striking inhibition
of syncytia formation by MVV-K1514 Env in T1514 cells,
CAEV-CO Env was able to induce syncytia of the same
size and to the same extent in either TIGEF or T1514 cells
(Figs. 4E and 4F), indicating that T1514 cells do express
functional SRLV receptor A. Collectively, the results indi-
cate that MVV-K1514 cannot use SRLV receptor A for
cell-to-cell fusion.
DISCUSSION
Infection and syncytium interference assays have
been used to determine common and differential recep-
tor usage of retroviruses when the identity of the recep-
tors is not known (Miller and Walgamot, 1997; Sommer-
felt and Weiss, 1990). These assays are usually per-
formed using infected cell lines with viral receptors
blocked by endogenously produced Env, which display
interference with homologous superinfection and forma-
tion of syncytia. However, most SRLV strains cannot
establish persistently infected cell lines without contin-
uous cell-to-cell fusion or lysis. In addition, cells acutely
infected with MVV-K1514 are permissive to homologous
superinfection (Haase et al., 1982), a characteristic
shared with other cytopathic retroviruses (Donahue et
al., 1991; Pauza et al., 1990; Weller et al., 1980). These
problems were solved by using exogenous soluble SU to
block host cell receptors. Soluble SU from CAEV and
North American MVV strains could efficiently block ho-
mologous receptors in infection interference assays.
However, the undiluted soluble SU of MVV-K1514 did not
block the receptors used by any SRLV pseudotype, in-
cluding the homologous CAEVneo(K1514), in contrast, for
example, with the 95% reduction of CAEVneo(CO) titers
in SSM cells by MVV-85/34 soluble SU when diluted
1:100 (not shown). The failure of MVV-K1514 SU to block
receptors could be due to an abnormal processing of
MVV-K1514 SU or an excess of receptors for this strain in
GSM and SSM cells. Alternatively, the binding affinity of
monomeric MVV-K1514 SU for its receptor(s) may be low,
similar to the low affinity (about 500 nM) of the human
immunodeficiency virus type 1 (HIV-1) SU for CXCR4. The
binding affinity of HIV-1 SU for CXCR4 is 50- to 100-fold
lower than the affinity of HIV-1 SU for CD4 or CCR5, too
low to detect SU-CXCR4 interactions in binding assays
(Hoffman et al., 2000). To overcome this problem, we
exploited the ability of Icelandic MVV strains to persis-
tently infect goat cell lines without cytopathic effects
(Andresson et al., 1993) by using a TIGEF cell line per-
sistently infected with MVV-K1514 and resistant to MVV-
K1514-induced fusion.
In summary, we show that CAEV and North American
MVV strains 85/34 and S93 use a common receptor
(SRLV receptor A) in sheep and goat cells as indicated by
the efficient cross-interference observed between these
strains. In contrast, the Icelandic MVV-K1514 uses a
second receptor (SRLV receptor B) as indicated by failure
of the SU from CAEV and North American MVV strains to
block the infectivity of CAEVneo(K1514) and the ability of
CAEV but not MVV-K1514 Env to induce syncytia in cells
persistently infected with MVV-K1514. Consistent with the
interpretation that SRLV use at least two different recep-
tors to infect GSM and SSM cells, we have recently found
that hamster  sheep somatic cell hybrid clones retain-
ing sheep chromosomes conferring susceptibility to
CAEVneo(K1514) are completely resistant to CAEV-
neo(85/34) (Ho¨tzel and Cheevers, 2002).
Our results confirm and extend the results of a study
describing different binding sites for whole virions from
the nonlytic CAEV and MVV-S93 and the lytic MVV-K1514
in sheep and goat cells (Jolly and Narayan, 1989). We
show that differential SRLV binding sites described in
that study reflect at least two different bona fide recep-
tors used for entry and syncytium formation in sheep and
goat cells. However, unlike other retroviruses, SRLV re-
ceptor usage is not related to cytopathic phenotype, as
the lytic MVV-85/34 and the nonlytic CAEV-CO and MVV-
S93 used SRLV receptor A for entry while the lytic MVV-
K1514 used SRLV receptor B. Instead, the differential
SRLV receptor usage is related to the infectivity of strains
to cells of different species (Ho¨tzel and Cheevers, 2001).
Whether other broadly tropic MVV strains like the British
MVV-EV1 strain (Lyall et al., 2000) also use SRLV receptor
B remains to be determined.
A relevant question is whether the receptor usage of
strains used in this study reflects the receptors used for
infection of macrophages and dendritic cells in vivo.
Determination of interference groups in cultured macro-
phages was not possible as drug selection requires
continuous cell proliferation. However, it is likely that
these receptors are used for infection of macrophages
since receptors were expressed in GSM and SSM cells
under normal culture conditions and not by overexpres-
sion of recombinant forms. In addition, cell types other
than those of the monocyte/macrophage lineage appear
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FIG. 4. Syncytial assays of MVV-K1514 and CAEV-CO Env in TIGEF or T1514 cells. TIGEF (A, C, and E) or T1514 cells (B, D, and F) were cocultured
2:1 with 293T cells transfected with control plasmid pCR3 (A and B) or plasmids expressing MVV-K1514 (C and D) or CAEV-CO Env (E and F).
Cocultured cells were incubated overnight, fixed in methanol, and stained with Giemsa.
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to express MVV receptors in vivo (Brodie et al., 1995;
Georgsson et al., 1989).
The ability of MVV-85/34 to efficiently bind to sheep
and goat cells independently of SRLV receptor A (Figs. 2
and 3A) suggests the presence of an additional receptor
involved in binding, but not entry, of a subset of SRLV
strains. MVV-S93 and CAEV-CO appear to lack this SRLV
receptor A-independent binding, indicating that it is Env-
dependent. Whether MVV-K1514 has a similar binding
activity could not be determined due to the resistance of
this strain to infection interference with soluble SU. This
binding activity is not an artifact of pseudotyping in hu-
man cells as similar results can be observed in interfer-
ence assays with wild-type MVV-85/34 and CAEV-CO
grown in GSM cells using syncytium formation to score
infectivity (not shown). The results in Fig. 3A indicate that
the SRLV receptor A-independent binding is not sufficient
for infection: CAEV-63 SU, which does not block this
binding, can completely block CAEVneo(85/34) entry if
added to the medium at high concentrations before and
after the challenge period. We suggest that either MVV-
85/34 Env itself or a host cell protein incorporated in the
envelope specifically selected by MVV-85/34 Env binds a
second putative receptor which mediates low-affinity
binding only rather than infection. Alternatively, the SRLV
receptor A-independent binding of MVV-85/34 to GSM
and SSM cells could be receptor independent. In either
case, the SRLV receptor A-independent binding of MVV-
85/34 could be a contributing factor in the much higher
infectivity of CAEVneo(85/34) relative to pseudotypes of
other SRLV strains to GSM cells (Ho¨tzel and Cheevers,
2001). Similar cell binding and enhancing activities have
been described for the SU of primate lentiviruses. For
instance, HIV-1 SU binds cell surface heparan sulfate
proteoglycans and SU of both human and simian immu-
nodeficiency viruses bind to the DC-SIGN and DC-SIGNR
lectins (Mondor et al., 1988; Geijtenbeek et al., 2000;
Po¨hlmann et al., 2001). All these binding activities can
facilitate virus infection through CD4 and coreceptors.
However, mannan, which binds to DC-SIGN and DC-
SIGNR, did not block the residual binding of CAEV-
neo(85/34) to GSM cells incubated with CAEV-63 SU (not
shown), indicating that these lectins are not involved in
binding of MVV-85/34 to GSM cells. Interestingly, one of
the proteins bound by MVV-K1514 on the surface of
sheep cells is a 30-kDa proteoglycan with chondroitin
sulfate side chains (Bruett et al., 2000), suggesting a
possible class of molecules involved in MVV-85/34 bind-
ing. Regardless of the mechanism for binding, our results
showing binding of MVV-85/34 to sheep and goat cells
independent of the receptor used for entry illustrate a
caveat of defining SRLV receptors and interference
groups based only on whole virus binding assays.
Interestingly, the interference assays suggest that
MVV and CAEV SU bind with higher affinity to sheep and
goat receptors, respectively. Although the IC50 of SU is
time-dependent in this assay, two patterns were consis-
tent in different experiments: the inhibition curves of
CAEV-63 SU were shifted toward a lower IC50 in GSM
cells relative to SSM cells by 3- to 10-fold (Figs. 2A and
2B), while the opposite was observed for the SU of both
North American MVV strains, whose inhibition curves
were shifted toward a higher IC50 in GSM cells relative to
SSM cells by a similar amount (not shown, but compare
the inhibition efficiencies in SSM and GSM cells in Table
1). This is reflected by the different efficiencies with
which pseudotypes infect sheep and goat cells: while
titers of CAEVneo(S93) and CAEVneo(85/34) were the
same or somewhat higher in SSM compared to GSM
cells, the titers of CAEVneo(CO) were consistently 3- to
10-fold lower in SSM cells compared to GSM cells in all
titration experiments (not shown). Thus, it appears that
CAEV and MVV Env, although able to mediate infection of
both sheep and goat cells, bind with higher affinity to
receptors from the species from which these viruses are
naturally isolated. This in turn could determine the rela-
tive efficiency with which these viruses replicate in in-
fected sheep and goats.
MATERIALS AND METHODS
Cells and virus
GSM cells were derived as previously described
(Crawford et al., 1980). SSM cells were derived from
explants of synovial membranes from the carpal joints of
a 4-month-old lamb. This lamb was seronegative for
CAEV SU as determined by competitive enzyme-linked
immunosorbent assay (O¨zyo¨ru¨k et al., 2001). In addition,
SSM cultures did not develop cytopathic effects charac-
teristic of SRLV infection upon passaging or cocultivation
with GSM cells. The human 293T cell line was obtained
from Richard Sutton (Baylor College of Medicine, Hous-
ton). The TIGEF cell line was obtained from Phillipe Lena
(Ecole Nationale Ve´te´rinaire de Lyon, France). All cells
were grown in Dulbecco’s modified Eagle’s medium
(DMEM), supplemented with 2 mM glutamine and 10%
fetal bovine serum (FBS). MVV-K1514 was grown in GSM
cells in DMEM with 2% FBS.
Derivation of T1514 cells
T1514 cells are TIGEF cells persistently infected with
MVV-K1514 that grow with normal fibroblast-like mor-
phology. Derivation of T1514 cells was similar to a pre-
viously described G-37 goat cell line persistently infected
with MVV-KV1772 (Andresson et al., 1993). Briefly, 5 105
TIGEF cells were seeded in a 25-cm2 flask and infected
with MVV-K1514 at a multiplicity of infection (MOI) of two
50% tissue culture infective doses (TCID50) per cell. After
the initial massive cell fusion and death, discrete clones
of cells with fibroblast-like morphology were defined by
resistance to MVV-K1514-induced lysis and fusion upon
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infection with virus at a MOI of two TCID50 per cell. These
cells, designated T1514, were passaged uncloned in
DMEM–10% FBS.
Production and titration of pseudotyped viruses
CAEVneo pseudotyped with the envelope glycopro-
teins of CAEV-CO, MVV-S93, MVV-85/34, MVV-K1514 or
vesicular stomatitis virus were produced by cotransfec-
tion of pCAEVneo10 and envelope plasmids pCMVCO2,
PCMV93, pCMV34, pCMV1514, or pMEVSVg in 293T cells
as previously described (Ho¨tzel and Cheevers, 2001).
CAEVneo pseudotypes for interference assays were fro-
zen in aliquots at 80°C and titrated on GSM and SSM
cells as previously described (Ho¨tzel and Cheevers,
2001) except that cells were incubated with virus for only
1 h and were then washed with 1 ml of DMEM without
serum to remove unbound virus.
Construction of soluble Env expression plasmids
Clones encoding soluble envelope glycoproteins of
North American MVV strains were constructed by intro-
ducing missense mutations in the region of env encoding
the carboxy terminus of the TM glycoprotein ectodomain.
Plasmid pCMV93S encoding a soluble MVV-S93 Env was
obtained by deleting the HindIII–EcoRI fragment in the
polylinker of pCMV93 (Ho¨tzel and Cheevers, 2001) and
introducing a 1-bp frameshift mutation in the region of
env encoding TM by digestion of this plasmid with
BamHI followed by a fill-in reaction and religation. Plas-
mid pCMV34S encoding a soluble MVV-34 Env was also
obtained by introducing a 1-bp frameshift mutation in
the region of env encoding TM by digestion of pCMV34
(Ho¨tzel and Cheevers, 2001) with NheI followed by a
fill-in reaction and religation. A soluble CAEV Env clone
was produced by PCR amplification of the CAEV-63 env
regions encoding the SU and TM ectodomains with prim-
ers ENVF (5-GGGAATTCGCGGCCGCGAGGAAAACT-
GGGTTGAAGTAACC-3) and ENVRTM (5-GGAGATCT-
TCAGAATTCAGACCTCTTTTAAGCTTTCCCATAC-3) us-
ing plasmid pC63-14B (Knowles et al., 1991) as template
for 30 cycles with an annealing temperature of 50°C. The
amplification product was digested with NotI and BglII
and cloned between the same sites of expression vector
VR1012 (Vical) to yield plasmid pCMV63S. This clone
requires Rev in trans for expression of Env. The CAEV-63
rev gene was cloned by RT-PCR amplification of oli-
go(dT)15-primed total RNA from CAEV-63-infected GSM
cells, purified with the Trizol Reagent (GIBCO-BRL, Grand
Island, NY). The rev open reading frame was amplified
with primers ENVF and REVR (5-GGGAGATCTTCATAGT-
GACTTGCTTTTCTTATAACACCA-3), and the amplifica-
tion product was cloned in the TA vector pCR3.1 (Invitro-
gen) to produce plasmid pCRev63. A soluble MVV-K1514
Env clone was produced by replacing the TM region of
env with a PCR amplification product obtained with prim-
ers VIS3F (5-AATATAACAGTAGGAAATGGAAC-3) and
VISTMR (5-GGGCTCGAGTTATTTGAGCCACGAGAAC-
CAAGAGG-3) using plasmid pCMV1514 as template for
30 cycles with an annealing temperature of 50°C. The
amplification product was digested with XbaI and XhoI
and cloned between the same sites of pCMV1514 yield-
ing pCMV1514S, truncated just before the anchor domain
of TM. This clone also requires Rev in trans for expres-
sion of Env. The MVV-K1514 rev gene was cloned by
RT-PCR amplification of oligo(dT)15-primed total RNA
from MVV-K1514-infected GSM cells. The rev open read-
ing frame was amplified with primers VISNAENVFE and
VISNAENVRX (Ho¨tzel and Cheevers, 2001) and the am-
plification product was cloned between the EcoRI and
XhoI sites of vector pCR3 (Invitrogen) to produce plasmid
pCRevV. Plasmids were sequenced to confirm the frame-
shift mutations and lack of PCR misincorporations.
Production of soluble SU
Native CAEV-63 soluble SU was purified by immuno-
affinity chromatography with monoclonal antibody F7-
299 as previously described (Kemp et al., 2000). CAEV-63
SU was more than 95% pure as determined by Coomas-
sie blue staining following sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis (SDS–PAGE). The con-
centration of purified CAEV-63 SU was determined with a
BCA assay kit (Pierce Chemical Co., Rockford, IL). Su-
pernatants containing recombinant soluble Env or con-
trol supernatants were produced by transfecting 3  106
human 293T cells in 100-mm plates with 10 g of
pCMV63S and pCRev63, 10 g of pCMV1514S and
pCRevV, or 20 g of pCMV93S, pCMV34S, or pCR3 by the
calcium phosphate coprecipitation method. Culture me-
dium was replaced with 16 ml of DMEM–10% FBS 18 h
posttransfection, and the conditioned culture medium
was harvested 72 h posttransfection, clarified by centrif-
ugation at 5000 g for 15 min and stored at 80°C. For
immunoprecipitation of recombinant soluble envelope
glycoproteins, transfected 293T cells in 25-cm2 flasks
were incubated in 4 ml methionine-free DMEM (GIBCO)
supplemented with 10% FBS and 100 Ci/ml [35S]methi-
onine. Supernatants were harvested 72 h posttransfec-
tion, clarified by centrifugation at 3000 g at 4°C for 20
min and filtered through a 0.2-m filter. Immune serum
from CAEV-63-infected goat 8517 and normal serum from
goat 8505 (10 l each) were used to immunoprecipitate
recombinant envelope glycoproteins in supernatants
(100 l each). Immunoprecipitated proteins were re-
solved by SDS–PAGE in a 4–20% gradient gel under
reducing conditions and detected by autoradiography.
Interference assays
GSM or SSM cells in 6-well plates (2  105 cells/well)
were incubated with 1 ml of recombinant soluble SU or
100.5 serial dilutions of purified CAEV-63 SU in DMEM–
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10% FBS in duplicate for 1 h at 37°C followed by the
addition of 100 l of DMEM–10% FBS containing 100
CFU of pseudotyped CAEVneo. After incubation of cells
with virus and SU for 1 additional h at 37°C, cells were
washed twice with 1 ml of DMEM and incubated for 24 h
in DMEM–10% FBS. In some experiments, DMEM–10%
FBS containing 160 nM CAEV-63 SU was added to the
cells after the wash. The next day cells were detached
from plates with trypsin and transferred to 60-mm plates
in DMEM–10% FBS with 750 g/ml of active G418
(GIBCO BRL). After 9 to 10 days of growth under selective
conditions, cells were stained with crystal violet and
colonies were counted. Incubation of GSM or SSM cells
with undiluted conditioned culture medium of 293T cells
transfected with control plasmid pCR3 did not signifi-
cantly affect titers of any CAEVneo pseudotype com-
pared to cells preincubated in fresh medium (not shown).
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